Skip to content

Public FDA record

Z-1656-2026: RefleXion X1 Radiotherapy System Model RXM1000, Part #800-00006-00

Recall record Z-1656-2026 for Reflexion Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1656-2026
Company in FDA record
Reflexion Medical, Inc.
FDA classification date
Mar 27, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose.

Source facts

Action
On 2/9/2026, recall notices were emailed to customers who were informed of the following: How to recognize that the device may fail: Any patient treatment with a roll offset applied in a localization followed by a subsequent repeat localization within the same treatment session will be affected. For patient treatments that have already occurred, measuring the approximate distance off-axis (R) and the maximum roll offset value (., in radians) can provide an approximate displacement value (S) through a simple mathematical formula, which may be helpful in estimating the severity of the dose impact for the patient. Customers were asked to do the following: 1) Notify your clinical staff of the recall, including posting this notification on or near the system until this issue can be resolved. 2) Halt utilization of the Repeat Localization feature for all treatment and imaging sessions. a. Note: Standard Roll corrections may still be used on the system if they are only applied in the localization immediately prior to the treatment delivery or imaging session commencing, as those are unaffected by this issue. 3) If a Roll correction is applied in an initial Localization and a Repeat Localization is initiated, the user should end the treatment session without continuing to treatment delivery or PET imaging. The user should restart the treatment session as a new treatment session to properly apply the Roll correction in the initial Localization without performing a Repeat Localization afterwards. 4) Complete and return the acknowledgement form. Questions or additional assistance can be sent to the firm at support@reflexion.com
Initiated
2026-02-09
Root cause
Software change control
Distribution
US: CA, TX, PA, CT, NJ, OR, LA, OH
Recall number
Z-1656-2026
Recall status
Open, Classified
CDRH record ID
218975
FDA classified
2026-03-27
Recall event number
98518

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗